THERALINK TECHNOLOGIES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Theralink Technologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q4 2023.
  • Theralink Technologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $44.2K, a 92.8% decline year-over-year.
  • Theralink Technologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $683K, a 93.2% decline year-over-year.
  • Theralink Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.25M, a 79.2% decline from 2022.
  • Theralink Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.02M, a 166% increase from 2021.
  • Theralink Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.26M, a 75.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $683K $44.2K -$568K -92.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $1.25M -$1.1M -$9.08M -114% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-05
Q2 2023 $10.3M $333K -$370K -52.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $10.7M $1.4M +$698K +99.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $10M $612K -$13.7K -2.19% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 $7.99M +$7.38M +1221% Aug 16, 2022 10-K 2024-01-05
Q2 2022 $2.64M $703K +$171K +32.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.47M $703K +$171K +32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.29M $626K +$35.7K +6.05% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q3 2021 $2.26M $605K +$168K +38.4% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-29
Q2 2021 $2.09M $532K +$160K +42.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.93M $532K +$272K +104% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $1.66M $590K +$374K +174% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-18
Q3 2020 $1.29M $437K +$223K +104% Jul 1, 2020 Sep 30, 2020 10-K 2022-01-13
Q2 2020 $1.06M $373K +$303K +437% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-28
Q1 2020 $760K $261K +$7.88K +3.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-27
Q4 2019 $752K $216K -$48.8K -18.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-09-27
Q3 2019 $801K $214K -$18.7K -8.02% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-19
Q2 2019 $820K $69.4K -$68.2K -49.6% Apr 1, 2019 Jun 30, 2019 10-Q 2021-06-11
Q1 2019 $888K $253K +$83.3K +49.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $805K $265K +$120K +82.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 $685K $233K +$77.8K +50.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $607K $138K -$59.5K -30.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 $667K $169K -$100K -37.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $767K $145K +$3.19K +2.25% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $764K $155K -$11.8K -7.05% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $775K $197K +$40.7K +26.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $735K $270K +$56.2K +26.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-06-19
Q4 2016 $678K $142K -$27.8K -16.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-05-31
Q3 2016 $706K $167K +$81.6K +95.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $625K $156K +$115K +278% Apr 1, 2016 Jun 30, 2016 10-Q 2017-09-14
Q1 2016 $510K $213K +$183K +612% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 $326K $170K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 $85.4K +$30.1K +54.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 $41.3K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $30K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $55.4K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.